For example, Komurov et al. reported that genes of the glucose-deprivation response network are up-regulated in lapatinib- (an EGFR/HER2 dual inhibitor) resistant conditions, thus providing an EGFR-independent mechanism of glucose uptake in cancer cells [19]. Here, ERBB2 is linked to cancer.